These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1915075)

  • 1. Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone.
    Hofmann C; Lorenz K; Colca JR
    Endocrinology; 1991 Oct; 129(4):1915-25. PubMed ID: 1915075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.
    Hofmann CA; Edwards CW; Hillman RM; Colca JR
    Endocrinology; 1992 Feb; 130(2):735-40. PubMed ID: 1733721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle.
    Weinstein SP; Holand A; O'Boyle E; Haber RS
    Metabolism; 1993 Oct; 42(10):1365-9. PubMed ID: 8412752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs.
    Matsuhisa M; Shi ZQ; Wan C; Lekas M; Rodgers CD; Giacca A; Kawamori R; Vranic M
    Diabetes; 1997 Feb; 46(2):224-31. PubMed ID: 9000698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
    Ikeda H; Taketomi S; Sugiyama Y; Shimura Y; Sohda T; Meguro K; Fujita T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin sensitization in diabetic rat liver by an antihyperglycemic agent.
    Hofmann C; Lorenz K; Williams D; Palazuk BJ; Colca JR
    Metabolism; 1995 Mar; 44(3):384-9. PubMed ID: 7885286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice.
    Tang Y; Osawa H; Onuma H; Nishimiya T; Ochi M; Makino H
    Diabetes; 1999 Sep; 48(9):1830-5. PubMed ID: 10480615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone: in vitro effects on rat hepatoma cells and in vivo liver hypertrophy in KKAy mice.
    Weinstock RS; Murray FT; Diani A; Sangani GA; Wachowski MB; Messina JL
    Pharmacology; 1997 Apr; 54(4):169-78. PubMed ID: 9211562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability.
    Sandouk T; Reda D; Hofmann C
    Endocrinology; 1993 Jul; 133(1):352-9. PubMed ID: 8319581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
    Furuta M; Yano Y; Gabazza EC; Araki-Sasaki R; Tanaka T; Katsuki A; Hori Y; Nakatani K; Sumida Y; Adachi Y
    Diabetes Res Clin Pract; 2002 Jun; 56(3):159-71. PubMed ID: 11947963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of glucose transport by pioglitazone in cultured muscle cells.
    el-Kebbi IM; Roser S; Pollet RJ
    Metabolism; 1994 Aug; 43(8):953-8. PubMed ID: 8052151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone hydrochloride inhibits cholesterol absorption and lowers plasma cholesterol concentrations in cholesterol-fed rats.
    Colca JR; Dailey CF; Palazuk BJ; Hillman RM; Dinh DM; Melchior GW; Spilman CH
    Diabetes; 1991 Dec; 40(12):1669-74. PubMed ID: 1756906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA miR-222 mediates pioglitazone beneficial effects on skeletal muscle of diet-induced obese mice.
    de Mendonça M; de Sousa É; da Paixão AO; Araújo Dos Santos B; Roveratti Spagnol A; Murata GM; Araújo HN; Imamura de Lima T; Passos Simões Fróes Guimarães DS; Silveira LR; Rodrigues AC
    Mol Cell Endocrinol; 2020 Feb; 501():110661. PubMed ID: 31770568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic insulin resistance in KKA(y) mice and its amelioration by pioglitazone do not involve alterations in phospholipase C activity.
    Bleasdale JE; Swanson ML
    Biochim Biophys Acta; 1993 Jun; 1181(3):240-8. PubMed ID: 8391325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin resistance-reducing effect of a new thiazolidinedione derivative, pioglitazone].
    Ikeda H; Sugiyama Y
    Nihon Yakurigaku Zasshi; 2001 May; 117(5):335-42. PubMed ID: 11411343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone increases insulin sensitivity by activating insulin receptor kinase.
    Kobayashi M; Iwanishi M; Egawa K; Shigeta Y
    Diabetes; 1992 Apr; 41(4):476-83. PubMed ID: 1318856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).
    Gibbs EM; Stock JL; McCoid SC; Stukenbrok HA; Pessin JE; Stevenson RW; Milici AJ; McNeish JD
    J Clin Invest; 1995 Apr; 95(4):1512-8. PubMed ID: 7706456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone ameliorates the lowered exercise capacity and impaired mitochondrial function of the skeletal muscle in type 2 diabetic mice.
    Takada S; Hirabayashi K; Kinugawa S; Yokota T; Matsushima S; Suga T; Kadoguchi T; Fukushima A; Homma T; Mizushima W; Masaki Y; Furihata T; Katsuyama R; Okita K; Tsutsui H
    Eur J Pharmacol; 2014 Oct; 740():690-6. PubMed ID: 24964389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.